Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.

NEXT STORY
Forty Seven, Inc. Prices Underwritten Public Offering of 4,860,000 Shares of Common Stock
PREV STORY
Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress

author_avatar
NASDAQ Market News

Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease

Data Presented at the 20th International Congress of Parkinson’s Disease & Movement Disorders in ...

author_avatar
NASDAQ Market News

Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting

author_avatar
NASDAQ Market News